Cite
HARVARD Citation
Gehin, J. et al. (n.d.). SAT0185 Certolizumab pegol serum levels ≥20 mg/l are associated with improvement in das28 in rheumatoid arthritis patients. data from the nor-dmard study. Annals of the rheumatic diseases. pp. 953-954. [Online].